Skip to content
10-K

Annual Report

US-China Biomedical Technology, Inc.

0001683168-19-001869

← back to feed
Filed
Jun 12, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Jun 12, 2019 19.8M sh
Operating Cash Flow FY 2019 · Feb 28, 2019 −$544.67K
Operating Cash Flow FY 2019 · Feb 28, 2018 −$400.89K
Stockholders Equity FY 2019 · Feb 28, 2019 $1.41K
Stockholders Equity FY 2019 · Feb 28, 2018 −$271.81K
Stockholders Equity FY 2019 · Feb 28, 2017 −$8.11K
Total Liabilities FY 2019 · Feb 28, 2019 $76.08K
Total Liabilities FY 2019 · Feb 28, 2018 $352.43K
Current Assets FY 2019 · Feb 28, 2019 $58.27K
Current Assets FY 2019 · Feb 28, 2018 $61.41K
Total Assets FY 2019 · Feb 28, 2019 $77.49K
Total Assets FY 2019 · Feb 28, 2018 $80.63K
Sga Expense FY 2019 · Feb 28, 2019 $522.06K
Sga Expense FY 2019 · Feb 28, 2018 $515.52K
Net Income FY 2019 · Feb 28, 2019 −$710.94K
Net Income FY 2019 · Feb 28, 2018 −$482.16K
Operating Income FY 2019 · Feb 28, 2019 −$522.06K
Operating Income FY 2019 · Feb 28, 2018 −$515.52K